Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEXT: Xenon in Ischemic Stroke
NCT05335109Phase 3Completed
- Sponsor
- Negovsky Research Institute of General Reanimatology
- Start
- Jan 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of xenon in ischemic stroke, sponsored by Negovsky Research Institute of General Reanimatology. Started Jan 2022; status: completed.
02
Drugs
xenon
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05335109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05335109.